In moderate DN, Metformin treatment not only affects the expression of OGT and OGA but also has a substantial impact on the overall O-GlcNAc modification status in DN samples, along with decreased MC proliferation and mesangial matrix accumulation, suggesting that its renoprotective effects are mediated through O-GlcNAc modification. Here, OGT is linked to liver dysplastic nodule.